COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2897: Articles 28961-28970  | Next

A Rapidly Deployable Negative Pressure Enclosure for Aerosol-Generating Medical Procedures
Chahal, A. M., Van Dewark, K., Gooch, R., Fukushima, E., Husdon, Z. M.
10.1101/2020.04.14.20063958 — Posted: 2020-04-18
Mesenchymal stromal cells for COVID-19: A living systematic review protocol
Rada, G., Corbalan, J., Rojas, P.
10.1101/2020.04.13.20064162 — Posted: 2020-04-18
Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions
Fears, A. C., Klimstra, W. B., Duprex, P., Hartman, A., Weaver, S. C., Plante, K. S., Mirchandani, D., Plante, J., Aguilar, P. V., Fernandez, D., Nalca, A., Totura, A., Dyer, D., Kearney, B., Lackemeyer, M., Bohannon, J. K., Johnson, R., Garry, R. F., Reed, D. S., Roy, C. J.
10.1101/2020.04.13.20063784 — Posted: 2020-04-18 Discussion: Onsite
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
Wang, J., Yu, L., Li, K.
10.1101/2020.04.13.20064295 — Posted: 2020-04-18
Significant expression of FURIN and ACE2 on oral epithelial cells may facilitate the efficiency of 2019-nCov entry
Mei, Z., Bingpeng, L., Hongbin, G., Xinhong, W., Kaibin, W., Mingxiao, L., Chang, L., Jianming, C., Learn-han, L., Cuiling, Q., Linhu, G., Lijing, W.
10.1101/2020.04.18.047951 — Posted: 2020-04-18 Discussion: Onsite
Pandemic Publishing: Medical journals drastically speed up their publication process for Covid-19
Horbach, S. P. J. M.
10.1101/2020.04.18.045963 — Posted: 2020-04-18 Discussion: Onsite
Potential microenvironment of SARS-CoV-2 infection in airway epithelial cells revealed by Human Protein Atlas database analysis
Leng, L., Ma, J., Zhang, L., Wei, L., Zhao, L., Zhu, Y., Wu, Z., Cao, R., Zhong, W.
10.1101/2020.04.16.045799 — Posted: 2020-04-18
The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection
Qi, J., Zhou, Y., Hua, J., Zhang, L., Bian, J., Liu, B., Zhao, Z., Jin, S.
10.1101/2020.04.16.045690 — Posted: 2020-04-18 Discussion: Onsite
Regulation of angiotensin converting enzyme 2 (ACE2) in obesity: implications for COVID-19
Al Heialy, S., Hachim, M. Y., Senok, A., Abou Tayoun, A., Hamoudi, R., Alsheikh-Ali, A., Alheialy, Q.
10.1101/2020.04.17.046938 — Posted: 2020-04-18
Coronavirus Infection and PARP Expression Dysregulate the NAD Metabolome: A Potentially Actionable Component of Innate Immunity
Heer, C. D., Sanderson, D. J., Alhammad, Y. M. O., Schmidt, M. S., Trammell, S. A. J., Perlman, S., Cohen, M. S., Fehr, A. R., Brenner, C.
10.1101/2020.04.17.047480 — Posted: 2020-04-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).